Fig 4.

Prostate cancer gene fusion classification. The ongoing effort to screen prostate cancer patients for gene fusions, in combination with the recent technology advances, has resulted in a comprehensive gene fusion landscape. This schematic highlights all published gene fusions categorized into ETS rearrangements, RAF kinase gene fusions, and SPINK1-positive, ETS rearrangement–negative prostate cancers. The percentages highlight the estimated frequency of each gene fusion on the basis of published screens.